Importing Pharmaceuticals: A Prescription For Disaster
June 20, 2019 Across the country and in Washington, elected officials are looking at how to reduce healthcare costs...
CASE Op-Ed – RealClear Health: Socialist Price Schemes Will Be Harmful to Patients
Matthew Kandrach – President, CASE June 3, 2019 – https://bit.ly/2KoGoEr A recent study published in Health Affairs reached a controversial conclusion, that...
Hospital Pricing: Nontransparent and Hurting Patients
As consumers, we all understand the need to shop around. When buying gas, a TV or even a car we...
CASE Op-Ed, Washington Times: No ‘Magic Pill’ for Lowering Costs
Gerard Scimeca – Chairman, CASE April 5, 2019 – https://bit.ly/2IfnhvI In the ongoing public debate on the best way to effectuate...
CASE Signs Letter to Congress in Support of Hatch-Waxman Amendment to Protect Healthcare Innovation
April 3, 2019 Committee on Energy and Commerce 2125 Rayburn House Office Building Washington, DC 20515 Dear Chairman Pallone, On...
CASE Blog: PBMs – The Bullies of the Healthcare System
March 6, 2019 We continue to support President Trump’s efforts and enthusiasm to bring down healthcare prices. Our suggestion: let’s...
Forced Mail-Order Pharmacies: Unfair to Patients and Wasteful
For most Americans, picking up a prescription is a routine ordeal. Though costs and co-pays can vary greatly, most...
The Six Protected Classes Are Protected For A Reason
We’ve been vocal about how the Trump Administration has championed patients in their efforts to lower the cost of...
A Suggestion To Bring Down Healthcare Costs
President Trump is expected to touch upon areas of agreement between both parties and all Americans. in tonight’s State of...
CASE Op-Ed, IJR: More Government Intervention Is a Dangerous Prescription for American Health Care
Gerard Scimeca – Chairman, CASE February 5, 2019 – https://bit.ly/2HTCLae Health care was the top issue when voters went to the polls in...
.@POTUS’ IRA is driving up Part D premiums for millions of Medicare beneficiaries, yet Dems like @SenSanders continue to help tout this disastrous legislation. The Biden-Harris @WhiteHouse is misleading the public on their policy’s real impact.
Two weeks from election day, the supposedly independent @FCC is proposing price regulation of #broadband by restricting what data plans companies can offer.
By prohibiting usage-based plans, the FCC would end up increasing prices FOR EVERYONE, including low-data users!
CASE Letter Urges FDA & FTC to Scrutinize Deal Between L’Oréal and Galderma -- "Both companies are currently under investigation or facing sizable lawsuits from claims that they have used harmful chemicals in their products."
https://caseforconsumers.org/2024/10/21/case-letter-urges-fda-ftc-to-scrutinize-deal-between-loreal-and-galderma/